Rigel Pharmaceuticals (RIGL) EPS (Weighted Average and Diluted): 2010-2025
Historic EPS (Weighted Average and Diluted) for Rigel Pharmaceuticals (RIGL) over the last 9 years, with Sep 2025 value amounting to $1.46.
- Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) rose 108.57% to $1.46 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.18, marking a year-over-year increase of 2709.09%. This contributed to the annual value of $0.99 for FY2024, which is 168.75% up from last year.
- According to the latest figures from Q3 2025, Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) is $1.46, which was down 55.49% from $3.28 recorded in Q2 2025.
- Rigel Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $3.28 for Q2 2025, and its period low was -$3.09 during Q4 2022.
- For the 3-year period, Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around $0.51, with its median value being $0.05 (2023).
- As far as peak fluctuations go, Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) plummeted by 2,107.14% in 2022, and later skyrocketed by 5,566.67% in 2025.
- Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.14 in 2021, then tumbled by 2,107.14% to -$3.09 in 2022, then soared by 101.62% to $0.05 in 2023, then skyrocketed by 1,520.00% to $0.81 in 2024, then soared by 108.57% to $1.46 in 2025.
- Its last three reported values are $1.46 in Q3 2025, $3.28 for Q2 2025, and $0.63 during Q1 2025.